Effect of exercise and high-fat diet on plasma adiponectin and nesfatin levels in mice

Experimental and Therapeutic Medicine

Volumn 2, Issue 2, 2011, Pages 369-373

  Chaolu, Huhe ^a   Asakawa, Akihiro ^a   Ushikai, Miharu ^a   Li, Ying Xiao ^a   Cheng, Kai Chun ^a   Li, Jiang Bo ^a   Zoshiki, Takahiro ^a   Terashi, Mutsumi ^a   Tanaka, Chie ^a   Atsuchi, Kaori ^a   Sakoguchi, Takeo ^a   Tsai, Minglun ^a   Amitani, Haruka ^a   Horiuchi, Masahisa ^a   Takeuchi, Toru ^a   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Exercise; High fat diet; Mouse; Nesfatin 1

Indexed keywords

ADIPONECTIN; ANOREXIGENIC AGENT; CHOLESTEROL; GLUCOSE; INSULIN; NESFATIN 1; PEPTIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; EXERCISE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79551616517     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.199     Document Type: Article

References (24)

1. Yamauchi T, Oike Y, Kamon J, et al: Increased insulin sensitivity despite lipodystrophy in crebbp heterozygous mice. Nat Genet 30: 221-226, 2002.
2. Hara K, Boutin P, Mori Y, et al: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51: 536-540, 2002.
3. Okamoto Y, Arita Y, Nishida M, et al: An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32: 47-50, 2000.
4. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
5. Hotta K, Funahashi T, Arita Y, et al: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
6. Hulver MW, Zheng D, Tanner CJ, et al: Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283: E861-E865, 2002.
7. Boudou P, Sobngwi E, Mauvais-Jarvis F, Vexiau P and Gautier JF: Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic men. Eur J Endocrinol 149: 421-424, 2003.
8. Yatagai T, Nishida Y, Nagasaka S, et al: relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 50: 233-238, 2003.
9. Oh-I S, Shimizu H, Satoh T, et al: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443: 709-712, 2006.
10. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK and Dun NJ: Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148: 5088-5094, 2007.
11. Kohno D, Nakata M, Maejima Y, et al: Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149: 1295-1301, 2008.
12. Stengel A, Goebel M, Yakubov I, et al: Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150: 232-238, 2009.
13. Shimizu H, Oh-I S, Hashimoto K, et al: Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150: 662-671, 2009.
14. Price TO, Samson WK, Niehoff ML and Banks WA: Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 28: 2372-2381, 2007.
15. Cowley MA and Grove KL: To be or NUCB2, is nesfatin the answer? cell Metab 4: 421-422, 2006.
16. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ and Baskin DG: Central nervous system control of food intake. Nature 404: 661-671, 2000.
17. Cox KL, Burke V, Beilin LJ and Puddey IB: A comparison of the effects of swimming and walking on body weight, fat distribution, lipids, glucose, and insulin in older women-the Sedentary women Exercise Adherence Trial 2. Metabolism 59: 1562-1573, 2010.
18. MacLean PS, Higgins JA, Wyatt HR, et al: Regular exercise attenuates the metabolic drive to regain weight after long-term weight loss. Am J Physiol Regul Integr Comp Physiol 297: 793-802, 2009.
19. Michailidou Z, Carter RN, Marshall E, et al: Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitaryadrenal axis and blood pressure adaptions to high-fat diet. FASEB J 22: 3896-3907, 2008.
20. Qi Y, Takahashi N, Hileman SM, et al: Adiponectin acts in the brain to decrease body weight. Nat Med 10: 524-529, 2004.
21. Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K and Kasai K: High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett 582: 1719-1724, 2008.
22. Li QC, Wang HY, Chen X, Guan HZ and Jiang ZY: Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 159: 72-77, 2010.
23. Su Y, Zhang J, Tang Y, Bi F and Liu JN: The novel function of nesfatin-1: anti-hyperglycemia. Biochem Biophys Res Commun 391: 1039-1042, 2010.
24. Foo KS, Brauner H, Ostenson CG and Broberger C: Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 204: 255-263, 2010.